Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Tetraphase Bets On I.V. Eravacycline Rerun As Antibiotic Market Influx Looms
May 17 2017
•
By
Lucie Ellis-Taitt
Tetraphase CEO Guy Macdonald Has High Hopes For Lead Antibiotic Despite Past Failure • Source: Tetraphase Pharmaceuticals
More from Anti-infective
More from Therapeutic Category